T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in OncologySteven M. Horwitz, Hema Sundar, Stephen M. Ansell et al.|Journal of the National Comprehensive Cancer Network|2022Cited by 172
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020Neha Mehta–Shah, Youn H. Kim, Sarah McCue Horwitz et al.|Journal of the National Comprehensive Cancer Network|2020Cited by 121
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021Steven M. Horwitz, Hema Sundar, Stephen M. Ansell et al.|Journal of the National Comprehensive Cancer Network|2020Cited by 62
Molecular signature incorporating the immune microenvironment enhances thyroid cancer outcome predictionGeorge Xu, Vivian Weiß, Matthew A. Loberg et al.|Cell Genomics|2023Cited by 23
Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemiaStephen A. Strickland, Adam C. Seegmiller, Aaron C. Shaver et al.|Leukemia Research|2018Cited by 21